1. Uiga: Pa'epa'e pe toetoe a pa'epa'e pa'epa'e, maualuga hygroscopic.
2. Punavai: Porcine intestina mucosa.
3. Fa'agasologa: O le sodium Heparin e maua mai le mucosa o le intestinal maloloina.
4. Faʻailoga ma faʻaoga: O lenei oloa e masani ona faʻaaogaina mo le puipuia o faʻamaʻi thromboembolic, aemaise lava mo le manaʻomia o le anticoagulant vave, e pei o: 1. Acute or chronic venous thrombosis poʻo le leai o se suiga tele o le tafe toto o le pulmonary embolism (PE). Heparin e mafai ona taofi le fa'aopoopoga o le embolus e fa'aalu se taimi mo le thrombolysis fa'afuase'i o le tino.2. Puipuia ma le togafitia ole Atrial fibrillation ma le embolism.3. Togafitiga o le vave fa'asalalauina o le intravascular coagulation(DIC).4. Puipuia ma le togafitia o le thrombosis alatoto peripheral po o le myocardial infarction.5. O isi in vitro anticoagulation: e pei o taotoga cardiovascular, in vitro circulation, hemodialysis, angiography, e mafai foi ona faʻaaogaina mo le tuiina poʻo le sauniuniga o suʻega toto, i le taimi nei o faʻamatalaga autu o le faʻaogaina o le heparin o le loloto vein thrombosis (DVT), PE ma le thrombosis. i tagata gasegase maualuga.
· Pasia le GMP Saina
· 27 tausaga o biological enzyme R&D talafaasolopito
· E mafai ona su'eina mea mata'utia
· Mulimuli i le USP、EPma tulaga fa'atau
· Auina atu i fafo i le silia ma le 30 atunuu ma itulagi
· O loʻo i ai le gafatia o pulega lelei faʻapitoa e pei ole US FDA, Iapani PMDA, Korea i Saute MFDS, ma isi.
Mea Su'ega | Kamupani Fa'amatalaga | ||
EP | USP | ||
Uiga | Pa'epa'e pe toetoe a pa'epa'e pa'epa'e, maualuga hygroscopic | ||
Fa'ailoaga | Thrombotest: Fa'afetaui | Fa'asinomaga Chromatographic: Fa'afetaui | |
1H NMR Alaleo: Fa'afetaui | 1H NMR Alaleo: Fa'afetaui | ||
Suavai Chromatography: Fa'afetaui | Mamafa-aveve mamafa molecular: 15000~19000 | ||
Sodium: E fetaui | Sodium: E fetaui | ||
Anti-factor Xa i le anti-factor IIa fua faatatau:0.9~1.1 | Anti-factor Xa i le anti-factor IIa fua faatatau:0.9~1.1 | ||
Su'ega | Malamalama ma lanu | Malamalama: manino, Lanu: e 5 pe sili atu | ———— |
Nitrogen | 1.5~2.5%(mea mamago) | 1.3~2.5%(mea mamago) | |
Nucleotidic le mama | A260≤ 0.15(4mg/ml) | ≤ 0.1(w/w) | |
Mea fa'atatau | Fa'atatau | ———— | |
Fa'atapula'a le galactosamine i le aofa'i o le hexosamine | ———— | ≤ 1.0% | |
Ova chondroitin sulfate | ———— | Fa'atatau | |
pH | 5.5~8.0(1%) | 5.5~7.5(1%) | |
Ma'imau ile fa'amago | ≤ 8.0%(60 ℃ Fa'agogo ile Vacuum, 3h) | ≤ 5.0%(60 ℃ Fa'agogo ile Vacuum, 3h) | |
Toega ile mu | ———— | 28.0%~41.0% | |
Endotoxin siama | ≤ 0.01 IU/Iunite Fa'avaomalo o Heparin | ≤ 0.03 USP U/Iunite Faava-o-malo o Heparin | |
Uamea mamafa | ≤ 30ppm | ≤ 30ppm | |
Sodium | 10.5~13.5%(mea mamago) | ———— | |
Polotini | ≤ 0.5%(mea mamago) | ≤ 0.1%(Fuafuaga o le mamafa) | |
Gaoioiga | ≥ 180 IU/mg(mea mamago) | ≥ 180 USP U/mg(mea mamago) | |
Microbial le mama | TAMC | ≤ 1000cfu/g | ≤ 1000cfu/g |
TYMC | ≤ 100cfu/g | ≤ 100cfu/g | |
E.coli | Fa'atatau | Fa'atatau | |
Staphylococcus aureus | Fa'atatau | Fa'atatau | |
Salmonella | Fa'atatau | Fa'atatau |